Hybrigenics has appointed Albert Saporta to its board as a non-executive independent director. He replaces Eric Castaldi, who has resigned. The company announced that board member Rene Kuijten has also resigned and will not be replaced.
Saporta is currently a board member of Stallergenes, where he was CEO prior to its acquisition by Ares Life Sciences in 2010.
People in the News: Hybrigenics Shuffles its Board
Premium